Leveraging Patient-Derived Models of FGFR2 Fusion Positive Intrahepatic Cholangiocarcinoma to Identify Synergistic Therapies

Researchers reported generation of a patient-derived FGFR2 fusion-positive intrahepatic cholangiocarcinoma model system consisting of a cell line, organoid, and xenograft.